UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank looks to expand its health-care dealmaking in the US.

RBC Capital Markets came out and announced that it has lowered its year-end S&P 500 (SP500) target along with its EPS ...

RBC Capital Markets joined a series of brokers lowering their 2025 expectations for the US stock market amid darkening ...

In a report released on March 20, Ashish Sabadra from RBC Capital maintained a Hold rating on Factset Research (FDS – Research Report), with a ...

The economic mood seems to be darkening and that has RBC Capital Markets analysts lowering their price target for the S&P 500 at the end of the year to 6,200 from 6,600. That still implies a roughly ...

RBC Capital analyst Scott Hanold maintained a Buy rating on Chord Energy (CHRD – Research Report) on March 20 and set a price target of ...

For the mid-term outlook covering 2026 and 2027, organic sales growth is projected between 3.5% and 3.7%, slightly below ...

Following the S&P 500's recent 10% drawdown, RBC Capital Markets head of US equity strategy Lori Calvasina lowered her year-end target to the S&P 500 to 6,200 from 6,600. Calvsina's revised ...

Royal Bank of Canada beat estimates on higher results in its capital-markets and wealth-management divisions as both units benefited from strong markets. Canada’s biggest lender earned C$3.62 ...